Search Results

By Laurie H. Sehn, MD, MPH, and Ciara L. Freeman, MD, PhD  / May 10, 2022 - Supplement: Hematologic Oncology Almanac

Hematologic Oncology 2021–2022 Almanac

Ongoing evaluation of novel, targeted, and immunotherapies has led to exciting advances across the array of hematologic malignancies over the past year. The availability of new treatment options, along with emerging data on novel combinations and sequencing approaches, is rapidly changing...